MedTrace Logo

Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study

NCT02144090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-07-10

No results posted yet for this study

Summary

The purpose of this study is to assess the usability and safety of the Opsens OptoWire and Optomonitor in measuring fractional flow reserve (FFR) in patients with coronary artery disease who are undergoing a coronary angiogram.

Conditions

  • Stable Angina
  • Unstable Angina Pectoris
  • Chest Pain
  • Ischemia

Interventions

DEVICE

Fractional flow reserve measurement

Fractional flow reserve measurement

Sponsors & Collaborators

  • Opsens, Inc.

    collaborator INDUSTRY

  • International Chair on Interventional Cardiology and Transradial Approach

    collaborator OTHER

  • Laval University

    lead OTHER

Principal Investigators

  • Olivier F Bertrand, MD PhD · International Chair on Interventional Cardiology and Transradial Approach

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02144090 on ClinicalTrials.gov